The effect of caltrop extract on renal stones
- Conditions
- urolithiasis.
- Registration Number
- IRCT20221225056918N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Renal stones between 6-10 mm (kidney sonography or spiral CT without contrast)
Renal stones without simultaneous symptoms ( uncontrollable pain and nausea and vomiting ) or referral pain
Number of stones: between 1-3 stones
The stones localize upper, middle and lower calyxes
Agreement of participant to inform consent and signing it's written form before recruiting in the study.
Age of participant between 18-60 yr both gender
The participant don't use other herbal or chemical drugs that effect on renal stones (allopurinol, indinavir, ).
Normal LFT (SGOT,SGPT, Alkaline Phosphatase), Normal KFT(BUN, Cr)
Consumption other types of chemical or herbal drugs except those prescribed in this study;
History of significant problems (diabetes mellitus, renal dysfunctions, hepatic dysfunctions and peptic ulcer)
other procedures or emergency interventions
Affecting by urinary stone complications (any grade of hydro-nephrosis and urinary tract infectious)
Subjects intending to withdraw at any time during the course of study
Pregnancy; Lactating
sensitivity to Caltrop
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of renal stones. Timepoint: Before intervention and two months after intervention. Method of measurement: Sonography or CT-scan without contrast.;Location of renal stones. Timepoint: Before inter vention and two months after intervention. Method of measurement: Sonography or CT-scan without contrast.;Number of stones. Timepoint: Before inter vention and two months after intervention. Method of measurement: Sonography or CT-scan without contrast.
- Secondary Outcome Measures
Name Time Method